Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Generic Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Generic Drug market. Detailed analysis of key players, along with key growth strategies adopted by Generic Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis company
Fresenius
Par Pharma
Greenstone
Aspen Pharmacare
Hospira
Allergan
Lupin
Stada
Mylan
Sun Pharmaceutical
By Type:
Pure (Non-branded) Generics
Branded Generics
Super Generics
By End-User:
Cardiovascular & Hypertension
Dermatology
Diabetes
Rheumatology
Oncology
Gastrointestinal
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Generic Drug Market
-
1.3 Market Segment by Type
-
1.3.1 Japan Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics from 2014 to 2026
-
1.3.2 Japan Generic Drug Market Size and Growth Rate of Branded Generics from 2014 to 2026
-
1.3.3 Japan Generic Drug Market Size and Growth Rate of Super Generics from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Market Size and Growth Rate of Cardiovascular & Hypertension
-
1.4.2 Market Size and Growth Rate of Dermatology
-
1.4.3 Market Size and Growth Rate of Diabetes
-
1.4.4 Market Size and Growth Rate of Rheumatology
-
1.4.5 Market Size and Growth Rate of Oncology
-
1.4.6 Market Size and Growth Rate of Gastrointestinal
-
1.4.7 Market Size and Growth Rate of Others
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Generic Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Generic Drug by Major Types
-
3.4.1 Japan Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics from 2014 to 2026
-
3.4.2 Japan Generic Drug Market Size and Growth Rate of Branded Generics from 2014 to 2026
-
3.4.3 Japan Generic Drug Market Size and Growth Rate of Super Generics from 2014 to 2026
4 Segmentation of Generic Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Generic Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Generic Drug in Cardiovascular & Hypertension
-
4.4.2 Market Size and Growth Rate of Generic Drug in Dermatology
-
4.4.3 Market Size and Growth Rate of Generic Drug in Diabetes
-
4.4.4 Market Size and Growth Rate of Generic Drug in Rheumatology
-
4.4.5 Market Size and Growth Rate of Generic Drug in Oncology
-
4.4.6 Market Size and Growth Rate of Generic Drug in Gastrointestinal
-
4.4.7 Market Size and Growth Rate of Generic Drug in Others
5 Market Analysis by Regions
-
5.1 Japan Generic Drug Production Analysis by Regions
-
5.2 Japan Generic Drug Consumption Analysis by Regions
6 Hokkaido Generic Drug Landscape Analysis
-
6.1 Hokkaido Generic Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Generic Drug Landscape Analysis by Major End-Users
7 Tohoku Generic Drug Landscape Analysis
-
7.1 Tohoku Generic Drug Landscape Analysis by Major Types
-
7.2 Tohoku Generic Drug Landscape Analysis by Major End-Users
8 Kanto Generic Drug Landscape Analysis
-
8.1 Kanto Generic Drug Landscape Analysis by Major Types
-
8.2 Kanto Generic Drug Landscape Analysis by Major End-Users
9 Chubu Generic Drug Landscape Analysis
-
9.1 Chubu Generic Drug Landscape Analysis by Major Types
-
9.2 Chubu Generic Drug Landscape Analysis by Major End-Users
10 Kinki Generic Drug Landscape Analysis
-
10.1 Kinki Generic Drug Landscape Analysis by Major Types
-
10.2 Kinki Generic Drug Landscape Analysis by Major End-Users
11 Chugoku Generic Drug Landscape Analysis
-
11.1 Chugoku Generic Drug Landscape Analysis by Major Types
-
11.2 Chugoku Generic Drug Landscape Analysis by Major End-Users
12 Shikoku Generic Drug Landscape Analysis
-
12.1 Shikoku Generic Drug Landscape Analysis by Major Types
-
12.2 Shikoku Generic Drug Landscape Analysis by Major End-Users
13 Kyushu Generic Drug Landscape Analysis
-
13.1 Kyushu Generic Drug Landscape Analysis by Major Types
-
13.2 Kyushu Generic Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
-
14.1 Novartis company
-
14.1.1 Novartis company Company Profile and Recent Development
-
14.1.2 Novartis company Market Performance
-
14.1.3 Novartis company Product and Service Introduction
-
14.2 Fresenius
-
14.2.1 Fresenius Company Profile and Recent Development
-
14.2.2 Fresenius Market Performance
-
14.2.3 Fresenius Product and Service Introduction
-
14.3 Par Pharma
-
14.3.1 Par Pharma Company Profile and Recent Development
-
14.3.2 Par Pharma Market Performance
-
14.3.3 Par Pharma Product and Service Introduction
-
14.4 Greenstone
-
14.4.1 Greenstone Company Profile and Recent Development
-
14.4.2 Greenstone Market Performance
-
14.4.3 Greenstone Product and Service Introduction
-
14.5 Aspen Pharmacare
-
14.5.1 Aspen Pharmacare Company Profile and Recent Development
-
14.5.2 Aspen Pharmacare Market Performance
-
14.5.3 Aspen Pharmacare Product and Service Introduction
-
14.6 Hospira
-
14.6.1 Hospira Company Profile and Recent Development
-
14.6.2 Hospira Market Performance
-
14.6.3 Hospira Product and Service Introduction
-
14.7 Allergan
-
14.7.1 Allergan Company Profile and Recent Development
-
14.7.2 Allergan Market Performance
-
14.7.3 Allergan Product and Service Introduction
-
14.8 Lupin
-
14.8.1 Lupin Company Profile and Recent Development
-
14.8.2 Lupin Market Performance
-
14.8.3 Lupin Product and Service Introduction
-
14.9 Stada
-
14.9.1 Stada Company Profile and Recent Development
-
14.9.2 Stada Market Performance
-
14.9.3 Stada Product and Service Introduction
-
14.10 Mylan
-
14.10.1 Mylan Company Profile and Recent Development
-
14.10.2 Mylan Market Performance
-
14.10.3 Mylan Product and Service Introduction
-
14.11 Sun Pharmaceutical
-
14.11.1 Sun Pharmaceutical Company Profile and Recent Development
-
14.11.2 Sun Pharmaceutical Market Performance
-
14.11.3 Sun Pharmaceutical Product and Service Introduction
The List of Tables and Figures (Totals 114 Figures and 140 Tables)
-
Figure Japan Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics from 2014 to 2026
-
Figure Japan Generic Drug Market Size and Growth Rate of Branded Generics from 2014 to 2026
-
Figure Japan Generic Drug Market Size and Growth Rate of Super Generics from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Market Size and Growth Rate of Cardiovascular & Hypertension
-
Figure Market Size and Growth Rate of Dermatology
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Rheumatology
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Gastrointestinal
-
Figure Market Size and Growth Rate of Others
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Generic Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Generic Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Generic Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Generic Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Generic Drug by Different Types from 2014 to 2026
-
Figure Japan Generic Drug Market Size and Growth Rate of Pure (Non-branded) Generics from 2014 to 2026
-
Figure Japan Generic Drug Market Size and Growth Rate of Branded Generics from 2014 to 2026
-
Figure Japan Generic Drug Market Size and Growth Rate of Super Generics from 2014 to 2026
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Generic Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Generic Drug by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Cardiovascular & Hypertension
-
Figure Market Size and Growth Rate of Dermatology
-
Figure Market Size and Growth Rate of Diabetes
-
Figure Market Size and Growth Rate of Rheumatology
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Gastrointestinal
-
Figure Market Size and Growth Rate of Others
-
Table Japan Generic Drug Production by Regions
-
Table Japan Generic Drug Production Share by Regions
-
Figure Japan Generic Drug Production Share by Regions in 2014
-
Figure Japan Generic Drug Production Share by Regions in 2018
-
Figure Japan Generic Drug Production Share by Regions in 2026
-
Table Japan Generic Drug Consumption by Regions
-
Table Japan Generic Drug Consumption Share by Regions
-
Figure Japan Generic Drug Consumption Share by Regions in 2014
-
Figure Japan Generic Drug Consumption Share by Regions in 2018
-
Figure Japan Generic Drug Consumption Share by Regions in 2026
-
Table Hokkaido Generic Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Generic Drug Consumption Share by Types in 2014
-
Figure Hokkaido Generic Drug Consumption Share by Types in 2018
-
Figure Hokkaido Generic Drug Consumption Share by Types in 2026
-
Table Hokkaido Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Generic Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Generic Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Generic Drug Consumption Share by End-Users in 2026
-
Table Tohoku Generic Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Generic Drug Consumption Share by Types in 2014
-
Figure Tohoku Generic Drug Consumption Share by Types in 2018
-
Figure Tohoku Generic Drug Consumption Share by Types in 2026
-
Table Tohoku Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Generic Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Generic Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Generic Drug Consumption Share by End-Users in 2026
-
Table Kanto Generic Drug Consumption by Types from 2014 to 2026
-
Table Kanto Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Generic Drug Consumption Share by Types in 2014
-
Figure Kanto Generic Drug Consumption Share by Types in 2018
-
Figure Kanto Generic Drug Consumption Share by Types in 2026
-
Table Kanto Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Generic Drug Consumption Share by End-Users in 2014
-
Figure Kanto Generic Drug Consumption Share by End-Users in 2018
-
Figure Kanto Generic Drug Consumption Share by End-Users in 2026
-
Table Chubu Generic Drug Consumption by Types from 2014 to 2026
-
Table Chubu Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Generic Drug Consumption Share by Types in 2014
-
Figure Chubu Generic Drug Consumption Share by Types in 2018
-
Figure Chubu Generic Drug Consumption Share by Types in 2026
-
Table Chubu Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Generic Drug Consumption Share by End-Users in 2014
-
Figure Chubu Generic Drug Consumption Share by End-Users in 2018
-
Figure Chubu Generic Drug Consumption Share by End-Users in 2026
-
Table Kinki Generic Drug Consumption by Types from 2014 to 2026
-
Table Kinki Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Generic Drug Consumption Share by Types in 2014
-
Figure Kinki Generic Drug Consumption Share by Types in 2018
-
Figure Kinki Generic Drug Consumption Share by Types in 2026
-
Table Kinki Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Generic Drug Consumption Share by End-Users in 2014
-
Figure Kinki Generic Drug Consumption Share by End-Users in 2018
-
Figure Kinki Generic Drug Consumption Share by End-Users in 2026
-
Table Chugoku Generic Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Generic Drug Consumption Share by Types in 2014
-
Figure Chugoku Generic Drug Consumption Share by Types in 2018
-
Figure Chugoku Generic Drug Consumption Share by Types in 2026
-
Table Chugoku Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Generic Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Generic Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Generic Drug Consumption Share by End-Users in 2026
-
Table Shikoku Generic Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Generic Drug Consumption Share by Types in 2014
-
Figure Shikoku Generic Drug Consumption Share by Types in 2018
-
Figure Shikoku Generic Drug Consumption Share by Types in 2026
-
Table Shikoku Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Generic Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Generic Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Generic Drug Consumption Share by End-Users in 2026
-
Table Kyushu Generic Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Generic Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Generic Drug Consumption Share by Types in 2014
-
Figure Kyushu Generic Drug Consumption Share by Types in 2018
-
Figure Kyushu Generic Drug Consumption Share by Types in 2026
-
Table Kyushu Generic Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Generic Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Generic Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Generic Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Generic Drug Consumption Share by End-Users in 2026
-
Table Company Profile and Development Status of Novartis company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis company
-
Figure Sales and Growth Rate Analysis of Novartis company
-
Figure Revenue and Market Share Analysis of Novartis company
-
Table Product and Service Introduction of Novartis company
-
Table Company Profile and Development Status of Fresenius
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fresenius
-
Figure Sales and Growth Rate Analysis of Fresenius
-
Figure Revenue and Market Share Analysis of Fresenius
-
Table Product and Service Introduction of Fresenius
-
Table Company Profile and Development Status of Par Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Par Pharma
-
Figure Sales and Growth Rate Analysis of Par Pharma
-
Figure Revenue and Market Share Analysis of Par Pharma
-
Table Product and Service Introduction of Par Pharma
-
Table Company Profile and Development Status of Greenstone
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Greenstone
-
Figure Sales and Growth Rate Analysis of Greenstone
-
Figure Revenue and Market Share Analysis of Greenstone
-
Table Product and Service Introduction of Greenstone
-
Table Company Profile and Development Status of Aspen Pharmacare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen Pharmacare
-
Figure Sales and Growth Rate Analysis of Aspen Pharmacare
-
Figure Revenue and Market Share Analysis of Aspen Pharmacare
-
Table Product and Service Introduction of Aspen Pharmacare
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Lupin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin
-
Figure Sales and Growth Rate Analysis of Lupin
-
Figure Revenue and Market Share Analysis of Lupin
-
Table Product and Service Introduction of Lupin
-
Table Company Profile and Development Status of Stada
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Stada
-
Figure Sales and Growth Rate Analysis of Stada
-
Figure Revenue and Market Share Analysis of Stada
-
Table Product and Service Introduction of Stada
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Sun Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical
-
Figure Revenue and Market Share Analysis of Sun Pharmaceutical
-
Table Product and Service Introduction of Sun Pharmaceutical
-
